30552988 |
The role of SRC family kinases in FLT3 signaling
Kazi, JU,
Rönnstrand, L
|
Int. J. Biochem. Cell Biol. |
2019 |
20111072 |
FES kinases are required for oncogenic FLT3 signaling
Voisset, E,
Lopez, S,
Chaix, A,
Georges, C,
Hanssens, K,
Prébet, T,
Dubreuil, P,
De Sepulveda, P
|
Leukemia |
2010 |
31066629 |
FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications
Kazi, JU,
Rönnstrand, L
|
Physiol. Rev. |
2019 |
11090077 |
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways
Mizuki, M,
Fenski, R,
Halfter, H,
Matsumura, I,
Schmidt, R,
Müller, C,
Grüning, W,
Kratz-Albers, K,
Serve, S,
Steur, C,
Büchner, T,
Kienast, J,
Kanakura, Y,
Berdel, WE,
Serve, H
|
Blood |
2000 |
17356133 |
Activation mechanisms of STAT5 by oncogenic Flt3-ITD
Choudhary, C,
Brandts, C,
Schwäble, J,
Tickenbrock, L,
Sargin, B,
Ueker, A,
Böhmer, FD,
Berdel, WE,
Müller-Tidow, C,
Serve, H
|
Blood |
2007 |
10698507 |
Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
Hayakawa, F,
Towatari, M,
Kiyoi, H,
Tanimoto, M,
Kitamura, T,
Saito, H,
Naoe, T
|
Oncogene |
2000 |
23103841 |
The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo
Nabinger, SC,
Li, XJ,
Ramdas, B,
He, Y,
Zhang, X,
Zeng, L,
Richine, B,
Bowling, JD,
Fukuda, S,
Goenka, S,
Liu, Z,
Feng, GS,
Yu, M,
Sandusky, GE,
Boswell, HS,
Zhang, ZY,
Kapur, R,
Chan, RJ
|
Leukemia |
2013 |
26515730 |
CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia
Bertoli, S,
Boutzen, H,
David, L,
Larrue, C,
Vergez, F,
Fernandez-Vidal, A,
Yuan, L,
Hospital, MA,
Tamburini, J,
Demur, C,
Delabesse, E,
Saland, E,
Sarry, JE,
Galcera, MO,
Mansat-De Mas, V,
Didier, C,
Dozier, C,
Récher, C,
Manenti, S
|
Oncotarget |
2015 |
15498859 |
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival
Kim, KT,
Baird, K,
Ahn, JY,
Meltzer, P,
Lilly, M,
Levis, M,
Small, D
|
Blood |
2005 |
12468433 |
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations
Mizuki, M,
Schwäble, J,
Steur, C,
Choudhary, C,
Agrawal, S,
Sargin, B,
Steffen, B,
Matsumura, I,
Kanakura, Y,
Böhmer, FD,
Müller-Tidow, C,
Berdel, WE,
Serve, H
|
Blood |
2003 |
12796379 |
Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells
Spiekermann, K,
Bagrintseva, K,
Schwab, R,
Schmieja, K,
Hiddemann, W
|
Clin. Cancer Res. |
2003 |
15003515 |
Flt3 mutation activates p21WAF1/CIP1 gene expression through the action of STAT5
Takahashi, S,
Harigae, H,
Kaku, M,
Sasaki, T,
Licht, JD
|
Biochem. Biophys. Res. Commun. |
2004 |
22411868 |
SRC is a signaling mediator in FLT3-ITD- but not in FLT3-TKD-positive AML
Leischner, H,
Albers, C,
Grundler, R,
Razumovskaya, E,
Spiekermann, K,
Bohlander, S,
Rönnstrand, L,
Götze, K,
Peschel, C,
Duyster, J
|
Blood |
2012 |
16627759 |
Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD
Rocnik, JL,
Okabe, R,
Yu, JC,
Lee, BH,
Giese, N,
Schenkein, DP,
Gilliland, DG
|
Blood |
2006 |